BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30695419)

  • 1. [Emotional Motivational Disorders in Rats as a Result of Diprotin A and Sitagliptin Administration in the First Postnatal Week].
    Krupina NA; Khlebnikova NN; Orlova IN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2016 May; 66(3):367-381. PubMed ID: 30695419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 polyunsaturated fatty acids when administered to lactating rats modify the development of experimental anxiety-depressive state in the rat pups exposed to the dipeptidyl peptidase-IV inhibitor diprotin A on the second - third weeks after the birth.
    Krupina NA; Khlebnikova NN
    Patol Fiziol Eksp Ter; 2016; 60(4):9-19. PubMed ID: 29244917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Gene Expression Profiles in Adult Rat Brain Structures after Neonatal Action of Dipeptidyl Peptidase-IV Inhibitors.
    Zubkov EA; Zorkina YA; Orshanskaya EV; Khlebnikova NN; Krupina NA; Chekhonin VP
    Neuropsychobiology; 2017; 76(2):89-99. PubMed ID: 29860255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl Peptidase 4 Inhibitors Diprotin A and Sitagliptin Administered on Weeks 2-3 of Postnatal Development Modulate Monoamine Metabolism in the Striatum of Adult Rats.
    Khlebnikova NN; Orshanskaya EV; Narkevich VB; Kudrin VS; Krupina NA
    Bull Exp Biol Med; 2017 Jun; 163(2):190-194. PubMed ID: 28726205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobehavioral effects of liraglutide and sitagliptin in experimental models.
    Kamble M; Gupta R; Rehan HS; Gupta LK
    Eur J Pharmacol; 2016 Mar; 774():64-70. PubMed ID: 26849938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental model of anxiety-depression state in rats exposed to inhibitor of dipeptidyl peptidase IV methionyl-2(S)-cyano-pyrrolidine in early postnatal period].
    Krupina NA; Kushnareva EIu; Khlebnikova NN; Zolotov NN; Kryzhanovskiĭ GN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2009; 59(3):360-72. PubMed ID: 19591403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized Study.
    Ferjan S; Janez A; Jensterle M
    Metab Syndr Relat Disord; 2017 Dec; 15(10):515-520. PubMed ID: 29064743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal proinflammatory challenge in male Wistar rats: Effects on behavior, synaptic plasticity, and adrenocortical stress response.
    Tishkina A; Stepanichev M; Kudryashova I; Freiman S; Onufriev M; Lazareva N; Gulyaeva N
    Behav Brain Res; 2016 May; 304():1-10. PubMed ID: 26851557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the molecular dynamics of type-2 diabetes drug target DPP-4 and its interaction with Sitagliptin and inhibitor Diprotin-A.
    Chakraborty C; Hsu MJ; Agoramoorthy G
    Cell Biochem Biophys; 2014 Nov; 70(2):907-22. PubMed ID: 24809328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial.
    Ramos A; Pereira E; Martins GC; Wehrmeister TD; Izídio GS
    Behav Brain Res; 2008 Nov; 193(2):277-88. PubMed ID: 18590774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase IV inhibition upregulates GLUT4 translocation and expression in heart and skeletal muscle of spontaneously hypertensive rats.
    Giannocco G; Oliveira KC; Crajoinas RO; Venturini G; Salles TA; Fonseca-Alaniz MH; Maciel RM; Girardi AC
    Eur J Pharmacol; 2013 Jan; 698(1-3):74-86. PubMed ID: 23051671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline.
    Gault VA; Lennox R; Flatt PR
    Diabetes Obes Metab; 2015 Apr; 17(4):403-13. PubMed ID: 25580570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System.
    Raschi E; Poluzzi E; Koci A; Antonazzo IC; Marchesini G; De Ponti F
    Nutr Metab Cardiovasc Dis; 2016 May; 26(5):380-6. PubMed ID: 27067162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety- and depressive-like profiles during early- and mid-adolescence in the female Wistar Kyoto rat.
    D'Souza D; Sadananda M
    Int J Dev Neurosci; 2017 Feb; 56():18-26. PubMed ID: 27845188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Annual monitoring of side effects of administering sitagliptin in patients with type 2 diabetes mellitus].
    Andel M; Skrha P; Kraml P; Potockova J; Hoffmanova I; Silhova E; Fontana J; Richterova A; Gadiredi M; Busek P; Sromova L; Šedo A
    Vnitr Lek; 2016; 62(6):455-61. PubMed ID: 27485843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous Pemphigoid Associated with the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in a Patient with Liver Cirrhosis Complicated with Rapidly Progressive Hepatocellular Carcinoma.
    Harada M; Yoneda A; Haruyama S; Yabuki K; Honma Y; Hiura M; Shibata M; Matsuoka H; Uchiwa Y
    Intern Med; 2017 Sep; 56(18):2471-2474. PubMed ID: 28824076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alopecia areata universalis under treatment with sitagliptin : Possible immunological effect of dipeptidyl peptidase-4 inhibitors?].
    Kohlmann J; Ferrer RA; Markovic A; Illes M; Kunz M
    Hautarzt; 2021 Jul; 72(7):607-609. PubMed ID: 33205256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in anxiety-like behavior and locomotor activity following prenatal and postnatal methamphetamine exposure in adult rats.
    Hrubá L; Schutová B; Šlamberová R
    Physiol Behav; 2012 Jan; 105(2):364-70. PubMed ID: 21884713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α
    Lovshin JA; Rajasekeran H; Lytvyn Y; Lovblom LE; Khan S; Alemu R; Locke A; Lai V; He H; Hittle L; Wang W; Drucker DJ; Cherney DZI
    Diabetes Care; 2017 Aug; 40(8):1073-1081. PubMed ID: 28550195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sitagliptin for Type 2 diabetes: a 2015 update.
    Lee M; Rhee MK
    Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):597-610. PubMed ID: 26000559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.